Commonly lower in IBS and a frequent probiotic target, though effect sizes vary widely.
Irritable bowel syndrome (IBS)
This methane-producing archaeon is enriched in constipation-predominant IBS and linked to slower transit.
Reported in HMDAD (2 cited studies).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Reported in HMDAD (1 cited study).
Sometimes implicated in IBS-like symptoms, but just as often found in healthy people — causation is unproven.
Reported both reduced and unchanged depending on cohort and IBS subtype.
The contested one: linked to IBS in some studies, yet associated with healthier, high-diversity guts in asymptomatic carriers.